February 18, 2021 01:42 PM EST
People
Manufacturing

End­points Man­u­fac­tur­ing: 5 Ques­tions with Ho­mol­o­gy Med­i­cines

Conner Mitchell

This week, I asked five ques­tions of Tim Kel­ly, the chief tech­nol­o­gy of­fi­cer at Ho­mol­o­gy Med­i­cines. Kel­ly has over two decades of ex­pe­ri­ence in man­u­fac­tur­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times